Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Khanna, Dinesh, Prof, Denton, Christopher P, Prof, Jahreis, Angelika, MD, van Laar, Jacob M, Prof, Frech, Tracy M, MD, Anderson, Marina E, FRCP, Baron, Murray, MD, Chung, Lorinda, MD, Fierlbeck, Gerhard, MD, Lakshminarayanan, Santhanam, MD, Allanore, Yannick, Prof, Pope, Janet E, MD, Riemekasten, Gabriela, Prof, Steen, Virginia, Prof, Müller-Ladner, Ulf, Prof, Lafyatis, Robert, MD, Stifano, Giuseppina, MD, Spotswood, Helen, PhD, Chen-Harris, Haiyin, PhD, Dziadek, Sebastian, PhD, Morimoto, Alyssa, PhD, Sornasse, Thierry, PhD, Siegel, Jeffrey, MD, Furst, Daniel E, Prof
Published in The Lancet (British edition) (25.06.2016)
Published in The Lancet (British edition) (25.06.2016)
Get full text
Journal Article